Kerydin FDA Approval History
FDA Approved: Yes (First approved July 7, 2014)
Brand name: Kerydin
Generic name: tavaborole
Dosage form: Topical Solution
Company: Anacor Pharmaceuticals, Inc.
Treatment for: Onychomycosis, Toenail
Kerydin (tavaborole) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails.
Development timeline for Kerydin
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
